The AFLOAT trial showed that atrial arrhythmias were commonly noted post-PFO closure on systematic intracardiac monitoring, but flecainide did not reduce the incidence of these atrial arrhythmias. All ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback